Back to 
Hudson Bay Capital Management LP
Hudson Bay Capital Management LP
ARQT
Showing 0 of 2 quarters
Position history for Hudson Bay Capital Management LP's holdings in Arcutis Biotherapeutics, Inc.
No. Hudson Bay Capital exited its ARQT (Arcutis Biotherapeutics) position in Q2 2024. Its Q1 2024 13F listed 225,000 shares worth $2.2M. Hudson Bay Capital first reported ARQT in Q1 2024 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ARQT: BlackRock, Inc., Jennison Associates LLC, FMR LLC